Jiali Xu
发表
Hong Shen,
Y. Shu,
Lingxiang Liu,
2013,
PloS one.
Li-wen Ma,
D. Luo,
Jiali Xu,
2014,
Drug design, development and therapy.
Hua Shen,
Y. Shu,
Yi-qian Liu,
2014,
Asian Pacific journal of cancer prevention : APJCP.
Yongmei Yin,
Y. Shu,
Lingxiang Liu,
2012,
Clinical lung cancer.
Yu Fan,
Jie Ding,
Jiali Xu,
2020,
Oncology letters.
Y. Shu,
Ming-de Huang,
Lingmin Hu,
2012,
Asian Pacific journal of cancer prevention : APJCP.
M. Xie,
Y. Shu,
Jiali Xu,
2022,
Cell death discovery.
G. Ren,
Yunhai Li,
Hongzhong Li,
2021,
Frontiers in Oncology.
D. Luo,
Jiali Xu,
Z. Yin,
2012,
The Journal of dermatological treatment.
D. Luo,
Jiali Xu,
Z. Yin,
2012,
Journal of cutaneous pathology.
Tingting Wang,
Y. Shu,
Lianke Liu,
2019,
OncoTargets and therapy.
Jianqing Wu,
Shuangshuang Wu,
Kai Wang,
2022,
DNA and cell biology.
Hongbing Shen,
Zhibin Hu,
Hongxia Ma,
2015,
Genes & Genomics.
Kun Xu,
Y. Shu,
X. Guan,
2021,
Oncogenesis.
Hongbing Shen,
Zhibin Hu,
Yongmei Yin,
2013,
Cancer Chemotherapy and Pharmacology.
R. Guo,
Jun Li,
Chen Zhang,
2023,
Oxidative medicine and cellular longevity.
Yongmei Yin,
Y. Shu,
Lingxiang Liu,
2013,
PloS one.
Lingxiang Liu,
Jiali Xu,
W. Gao,
2017,
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
Jia-an Zhang,
Yang Xu,
Di Wu,
2014,
Drug design, development and therapy.
Yongmei Yin,
R. Guo,
Yang Yang,
2015,
BioMed research international.
Tingting Wang,
Tongshan Wang,
Y. Shu,
2021,
Oral oncology.
Y. Shu,
Lingxiang Liu,
Ping Liu,
2012,
Asian Pacific journal of cancer prevention : APJCP.
Y. Shu,
Lingxiang Liu,
Ping Liu,
2012
.
Tong-fu Yu,
R. Guo,
Jiali Xu,
2019,
Front. Oncol..
Lianke Liu,
K. Shen,
Jiali Xu,
2021,
OncoTargets and therapy.
Yongmei Yin,
Y. Shu,
S. Cao,
2013,
PloS one.
Liyong Pu,
Xuehao Wang,
Yongxiang Xia,
2022,
Nature communications.
Yongmei Yin,
Y. Shu,
Lingxiang Liu,
2014,
Lung cancer.
Yongmei Yin,
Yanhong Gu,
W. De,
2018,
Cell proliferation.
Effects of topical pimecrolimus 1% on high-dose ultraviolet B-irradiated epidermal Langerhans cells.
D. Luo,
Jiali Xu,
Z. Yin,
2012,
International immunopharmacology.
Y. Shu,
Jiali Xu,
Rongsheng Wang,
2020,
Chinese medical journal.
Yongmei Yin,
Yanhong Gu,
R. Guo,
2018,
American journal of translational research.
D. Luo,
Yongqiang Li,
Jiali Xu,
2014,
Drug design, development and therapy.
Hongbing Shen,
Yuzhuo Wang,
Zhibin Hu,
2015,
Medicine.
Yongmei Yin,
Lei Cao,
Xi-rui Wang,
2012
.
R. Guo,
Liang Chen,
Jiali Xu,
2021,
Journal of thoracic disease.
Wei Wang,
Jing Zhu,
R. Guo,
2022,
Journal of Cancer Research and Clinical Oncology.
Y. Shu,
Yi-qian Liu,
Xiaofeng Chen,
2014,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis
Qianghu Wang,
R. Guo,
Chunxiao Sun,
2022,
Journal for immunotherapy of cancer.
D. Luo,
Jiali Xu,
Z. Yin,
2011,
Journal of biomedical research.
Y. Shu,
Wei Li,
Lingxiang Liu,
2018,
Front. Oncol..
D. Luo,
Jiali Xu,
Z. Yin,
2018,
Front. Pharmacol..
Jiali Xu,
Z. Yin,
J. Tu,
2017,
Front. Immunol..
Y. Shu,
Lingmin Hu,
Jiali Xu,
2012,
Asian Pacific journal of cancer prevention : APJCP.
Tingting Wang,
Tongshan Wang,
Y. Shu,
2020
.
Wei Wang,
R. Guo,
Fang Zhang,
2022,
American journal of cancer research.
Yu Fan,
Jie Ding,
Jiali Xu,
2021,
Experimental and therapeutic medicine.
Yongmei Yin,
Y. Shu,
Lingxiang Liu,
2012,
Clinical lung cancer.
Yongmei Yin,
Y. Shu,
Lingxiang Liu,
2014,
Lung cancer.